Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots purchased 5 shares of the company’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of GBX 2,850 per share, for a total transaction of £142.50.
Steve Foots also recently made the following trade(s):
- On Tuesday, May 5th, Steve Foots sold 73 shares of Croda International stock. The shares were sold at an average price of GBX 2,840, for a total value of £2,073.20.
- On Friday, April 10th, Steve Foots acquired 5 shares of Croda International stock. The shares were acquired at an average price of GBX 2,950 per share, with a total value of £147.50.
- On Tuesday, March 17th, Steve Foots sold 3,622 shares of Croda International stock. The stock was sold at an average price of GBX 2,606, for a total value of £94,389.32.
- On Tuesday, March 10th, Steve Foots bought 6 shares of Croda International stock. The stock was acquired at an average price of GBX 2,798 per share, for a total transaction of £167.88.
Croda International Stock Performance
Croda International stock traded down GBX 20 during mid-day trading on Tuesday, hitting GBX 2,802. 1,193,682 shares of the company’s stock traded hands, compared to its average volume of 4,409,664. The firm has a 50 day moving average price of GBX 2,850.04 and a 200 day moving average price of GBX 2,823.88. The company has a quick ratio of 2.25, a current ratio of 1.99 and a debt-to-equity ratio of 31.85. The company has a market cap of £3.90 billion, a PE ratio of 63.11, a price-to-earnings-growth ratio of 1.40 and a beta of 0.94. Croda International Plc has a one year low of GBX 2,426.77 and a one year high of GBX 3,312.
Analyst Ratings Changes
CRDA has been the topic of several research analyst reports. Jefferies Financial Group reissued a “hold” rating and set a GBX 3,000 target price on shares of Croda International in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating for the company in a research note on Tuesday, March 24th. Finally, Morgan Stanley upgraded shares of Croda International to an “overweight” rating and increased their price objective for the company from GBX 3,280 to GBX 3,350 in a report on Wednesday, March 25th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Croda International has a consensus rating of “Moderate Buy” and an average target price of GBX 3,140.
Get Our Latest Stock Analysis on Croda International
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Featured Stories
- Five stocks we like better than Croda International
- MP Materials Is Quietly Building a Rare Earth Powerhouse
- AI Demand Fuels Strong Q1 Earnings for Constellation Energy
- Sony’s $4 Billion Bet on Rock & Roll Royalties
- Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
